Misophonia Successfully Treated of With Fluoxetine: A Case Report
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objective A large number of people experience misophonia. In 2013, the Amsterdam Study Group recommended diagnostic criteria for misophonia. However, misophonia is not yet included in the Diagnostic and Statistical Manual of Mental Disorders. This report is the first report on drug use that directly affects misophonia and demonstrates a 14-year-old adolescent girl with misophonia successfully treated with fluoxetine. Methods The patient's misophonia symptoms had been continuing for approximately 2 years, and her quality of life was significantly reduced. Psychotherapy conditions could not be applied, and fluoxetine 10 mg/d was started and increased to 20 mg/d after a week. At the second-month follow-up, because of partial improvement, fluoxetine dose was increased to 30 mg/d. Results At the fourth-month follow-up, there was a 40% decrease in Amsterdam Misophonia Scale score with a 70% decrease in the children's global assessment scale scores. By the 16th week, the overall functionality level was good at the end. Conclusions Fluoxetine may be used as an effective drug in the treatment of misophonia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This particular study showed the case of a 14-year-old adolescent girl with misophonia successfully treated with fluoxetine.”
From Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field (2022) · cites this paper as [87]
In the citing paper
“In the fourth month of treatment, there was a 40% decrease in the Children’s Global Assessment Scale (CGA) score [87].”
From Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field (2022) · cites this paper as [87]
In the citing paper
“Regarding the third block of treatments, those related to cognitive-behavioral therapies have been widely used showing that they can help to decrease misophonia symptoms and improve the patient’s quality of life [14,56,87].”
From Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field (2022) · cites this paper as [87]
Citations
Cites
Misophonia: Diagnostic Criteria for a New Psychiatric Disorder
Schröder, A., Vulink, N., & Denys, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054706 · Cited by 410
Misophonia: Incidence, Phenomenology, and Clinical Correlates in an Undergraduate Student Sample
Wu, M. S., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2014) · Journal of Clinical Psychology · doi:10.1002/jclp.22098 · Cited by 360
Misophonia: Phenomenology, comorbidity and demographics in a large sample
Jager, I., de Koning, P., Bost, T., Denys, D., & Vulink, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0231390 · Cited by 271
A Large-Scale Study of Misophonia
Rouw, R., & Erfanian, M. (2018) · Journal of Clinical Psychology · doi:10.1002/jclp.22500 · Cited by 262
Brout, J. J., Edelstein, M., Erfanian, M., Mannino, M., Miller, L. J., Rouw, R., Kumar, S., & Rosenthal, M. Z. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00036 · Cited by 198
(2015) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-62630-1.00021-4 · Cited by 151
Cognitive behavioral therapy is effective in misophonia: An open trial
Schröder, A. E., Vulink, N. C., van Loon, A. J., & Denys, D. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.017 · Cited by 139
Pediatric misophonia with comorbid obsessive-compulsive spectrum disorders
Webber, T. A., Johnson, P. L., & Storch, E. A. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.10.018 · Cited by 80
Misophonia in Children with Tic Disorders: A Case Series
Robinson, S. J., Hedderly, T. J., Conte, G., Malik, O., & Cardona, F. (2018) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000563 · Cited by 26
A little known topic misophonia: two case reports
Hocaoğlu, Ç. (2018) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2018310109 · Cited by 25
Cited by
Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field
Ferrer-Torres, A., & Giménez-Llort, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116790 · Cited by 64
“Regarding the third block of treatments, those related to cognitive-behavioral therapies have been widely used showing that they can help to decrease misophonia symptoms and improve the patient’s quality of life [14,56,87].”
BackgroundClinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia
Guzick, A. G., Cervin, M., Smith, E. E. A., Clinger, J. W., Draper, I. A., Goodman, W. K., Lijffijt, M., Murphy, N., Lewin, A. B., Schneider, S. C., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.083 · Cited by 64
A systematic review of treatments for misophonia
Mattson, S. A., D’Souza, J. M., Wojcik, K. D., Guzick, A. G., Goodman, W. K., & Storch, E. A. (2023) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2023.100104 · Cited by 47
β-Blockers for the Treatment of Misophonia and Misokinesia
Webb, J. (2022) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000492 · Cited by 18
MDMA for the treatment of misophonia, a proposal
Webb, J., & Keane, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.983285 · Cited by 7
Metadata
- Authors
- Sarigedik, E., & Yurteri, N.
- Affiliations
- Düzce Atatürk Devlet Hastanesi (TR)
- ORCID
- Yurteri, Nihal
- Venue
- Clinical Neuropharmacology
- Published
- 2021-07-14
- Volume
- 44
- Issue
- 5
- Pages
- 191-192
- ISSN
- 0362-5664 (ISSN-L)
- 1537-162X
- OpenAlex
- W3179887220
- Semantic Scholar
- 217d859bcce3a3d7be3539073e8124ecc6bb8de6
- Cited by
- 19
- References
- 10
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 8
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-01-01)
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Keywords
- misophonia, fluoxetine, pharmacotherapy, adolescents, quality of life, Children's Global Assessment Scale, selective serotonin reuptake inhibitors
- MeSH terms
- Adolescent, Child, Female, Fluoxetine, Humans, Quality of Life, Hyperacusis, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Misophonia Successfully Treated of With Fluoxetine: A Case Report. https://app.cochat.ai/papers/10.1097/wnf.0000000000000465
- The paper
- Sarigedik, E., & Yurteri, N. (2021). Misophonia Successfully Treated of With Fluoxetine: A Case Report. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000465
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.